Literature DB >> 10416476

Severe neurologic sequelae in a dog after treatment of hypoadrenal crisis.

C A Brady1, C H Vite, K J Drobatz.   

Abstract

A 3-year-old mixed-breed dog was evaluated for lethargy, weakness, anorexia, and vomiting. The dog was dehydrated, hyponatremic, hypochloremic, and hypoglycemic. Results of an ACTH stimulation test indicated hypoadrenocorticism. Treatment to restore cardiovascular stability and serum electrolyte balance caused serum sodium concentration to increase by 32 mEq/L within 48 hours, and the dog developed severe neurologic signs that persisted for approximately 3 weeks. Magnetic resonance imaging revealed cerebrocortical lesions on day 6 and more severe lesions, including diffuse atrophy of the cerebral hemispheres, at 23 weeks after initial evaluation; however, the dog recovered complete neurologic function. Serum sodium concentration should be monitored during treatment for hypoadrenal crisis to avoid rapid increases that can cause CNS damage.

Entities:  

Mesh:

Year:  1999        PMID: 10416476

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  5 in total

1.  Canine hypoadrenocorticism: part II.

Authors:  Susan C Klein; Mark E Peterson
Journal:  Can Vet J       Date:  2010-02       Impact factor: 1.008

2.  Case Report: Hindlimb Ataxia Concurrent With Seizures by Presumed Osmotic Demyelination Syndrome in a Dog.

Authors:  Ga-Won Lee; Min-Hee Kang; Hee-Myung Park
Journal:  Front Vet Sci       Date:  2022-06-17

3.  Neurologic complications following treatment of canine hypoadrenocorticism.

Authors:  Karen L MacMillan
Journal:  Can Vet J       Date:  2003-06       Impact factor: 1.008

Review 4.  Management of hypoadrenocorticism (Addison's disease) in dogs.

Authors:  Patty Lathan; Ann L Thompson
Journal:  Vet Med (Auckl)       Date:  2018-02-09

Review 5.  Crystalloid and Colloid Compositions and Their Impact.

Authors:  Elke Rudloff; Kate Hopper
Journal:  Front Vet Sci       Date:  2021-03-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.